Report overview
This report contains market size and forecasts of Retinal Disorder Drug in Global, including the following market information:
Global Retinal Disorder Drug Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Retinal Disorder Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Glaucoma Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Retinal Disorder Drug include Novartis Allergan, Roche, Valeant, Regeneron, Alcon inc., Pfizer inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and Bausch and Lomb Incorporated, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Retinal Disorder Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Retinal Disorder Drug Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Retinal Disorder Drug Market Segment Percentages, by Type, 2022 (%)
Glaucoma
Dry Eye Syndrome
Global Retinal Disorder Drug Market, by Distribution Channel, 2018-2023, 2023-2030 ($ millions)
Global Retinal Disorder Drug Market Segment Percentages, by Distribution Channel, 2022 (%)
Hospital Pharmacy
Drugs Store
Online Pharmacies
Global Retinal Disorder Drug Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Retinal Disorder Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Retinal Disorder Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Retinal Disorder Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis Allergan
Roche
Valeant
Regeneron
Alcon inc.
Pfizer inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Bausch and Lomb Incorporated
